首页> 外国专利> NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS

NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS

机译:新型化合物在治疗中枢神经系统疾病和疾病中的优势

摘要

A series of novel compounds showing anticonvulsantactivity is described. Such pharmaceutically active compoundsmay also show utility in the treatment of other central nervoussystem ("CNS") diseases and disorders, such as anxiety, depression,insomnia, migraine headaches, schizophrenia, Parkinson's disease,spasticity, Alzheimer's disease, and bipolar disorder. Furthermore,such compounds may additionally find utility as analgesics (e.g.,for the treatment of chronic or neuropathic pain) and asneuroprotective agents useful in the treatment of stroke(s), chronicneurodegenerative diseases (such as Alzheimer's disease and Huntington'sdisease), and/or traumatic brain and/or spinal cord injuries. More-over,these/such compounds may also be useful in the treatment ofstatus epilepticus and/or as chemical countermeasures.
机译:一系列具有抗惊厥作用的新型化合物描述了活动。此类药物活性化合物可能在其他中枢神经的治疗中也显示出效用系统(“ CNS”)疾病和失调,例如焦虑症,抑郁症,失眠,偏头痛,精神分裂症,帕金森氏病,痉挛,阿尔茨海默氏病和躁郁症。此外,这类化合物还可以用作止痛药(例如,用于治疗慢性或神经性疼痛)和神经保护剂可用于治疗慢性中风神经退行性疾病(例如阿尔茨海默氏病和亨廷顿病)疾病)和/或脑部和/或脊髓损伤。此外,这些/这类化合物也可用于治疗癫痫持续状态和/或作为化学对策。

著录项

  • 公开/公告号CA2718723C

    专利类型

  • 公开/公告日2018-05-08

    原文格式PDF

  • 申请/专利权人 AURIMMED PHARMA INC.;

    申请/专利号CA20092718723

  • 发明设计人 PESYAN AMIR;BALANDRIN MANUEL F.;

    申请日2009-03-18

  • 分类号A61K31/165;A61K31/277;A61K31/343;A61K31/357;A61K31/5375;A61P25;C07C253/30;C07C233/01;

  • 国家 CA

  • 入库时间 2022-08-21 12:48:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号